Zimmer Biomet stock gains on headquarters move and year-to-date rise

Zimmer Biomet stock has advanced nearly 10 percent since the start of 2026 while the company prepares a headquarters consolidation in Warsaw and donates its current building to a local college.

Zimmer Biomet Holdings, Inc. (ISIN US98956P1021) stock is trading close to the 100 dollar mark, with data from September 3, 2026 showing a level just under 99 dollars and a year-to-date gain of 9.9 percent for investors who held the shares since the start of 2026, according to market data compiled by MarketBeat and Yahoo Finance.

Headquarters consolidation adds a strategic angle

A fresh operational catalyst for Zimmer Biomet is a reorganization of its global headquarters footprint in Warsaw, Indiana. According to a local report by WANE dated September 3, 2026, the medical technology group plans to move its global hub into the same location where it already operates what is described as the world's largest orthopedic manufacturing facility at 1800 W. Center Street in Warsaw.

At the same time, Zimmer Biomet intends to donate its current headquarters building on East Main Street to a local college, creating a visible commitment to education and community development while reducing its own real estate footprint, as highlighted again by WSBT on September 4, 2026.

Zimmer Biomet stock performance and valuation context

In the market, Zimmer Biomet stock has been relatively stable but upward-sloping in 2026. MarketBeat data from September 3, 2026 indicate that the shares were changing hands at 98.88 dollars, down 0.62 dollars or 0.62 percent on that trading day, after rising from 89.94 dollars at the beginning of 2026, which corresponds to a 9.9 percent increase year-to-date.

The latest intraday snapshot from Yahoo Finance on September 3, 2026 shows Zimmer Biomet stock at 98.72 dollars, a decline of 0.78 dollars or 0.78 percent during the session at around 2:07 PM Eastern time, illustrating modest short-term volatility around the 100 dollar level and providing investors with a reference point for current trading conditions.

This year-to-date gain, while not dramatic, suggests that Zimmer Biomet stock has outperformed many defensive healthcare names that have seen flatter trajectories in 2026, and it may reflect investors' expectations that operational moves like the Warsaw headquarters consolidation will support margin stability and execution in the core orthopedic implants business.

Orthopedic implants remain the core business

Zimmer Biomet's core business remains the design, manufacture and marketing of orthopedic reconstructive implants, including hip and knee replacement systems, as well as a broad range of supplies and surgical equipment used in orthopedic surgery, as described in an overview of the company on a stock-price information page operated by Coindesk.

The Warsaw manufacturing site that will host the consolidated headquarters is described as the world's largest orthopedic manufacturing facility, underlining how closely Zimmer Biomet's corporate center is tied to its production base and suggesting that integrating management and operations at the same location could streamline decision-making and product rollouts.

Stock price snapshot and investor takeaway

Based on the most recent closing and intraday data available as of September 3, 2026, Zimmer Biomet stock can be summarized as trading around 98.8 to 98.7 dollars on the New York Stock Exchange, reflecting a year-to-date increase of 9.9 percent from 89.94 dollars at the beginning of 2026 and a short-term daily movement of roughly minus 0.6 to minus 0.8 percent on that trading day.

Zimmer Biomet stock facts

• Company: Zimmer Biomet Holdings, Inc.
• ISIN: US98956P1021
• Ticker: ZBH
• Trading venue: NYSE
• Price (as of September 3, 2026, 03:58): 98.88 USD
• Market capitalization: [value] USD (as of September 3, 2026)
• Sector / Industry: Health Care / Medical Devices
• Index membership: S&P 500